An unresolved question about signal transduction was purified and identified as the product of the within the R7 cell is whether all the effects of SEV activadaughter of sevenless (dos) gene. Mutations of dos tion are mediated through the activation of RAS1 by were identified in a screen for dominant mutations DRK and SOS. Our previous studies have suggested which enhance the phenotype caused by overexpresthe existence of a second signaling pathway whose sion of inactive CSW during photoreceptor developfunction is required during SEV signaling (Allard et al., ment. Analysis of dos mutations indicates that DOS is 1996). We identified dominantly inhibiting and constitua positive component of the SEV signaling pathway tively signaling forms of corkscrew (CSW), a phosphotyand suggests that DOS dephosphorylation by CSW rosine phosphatase (PTP) that contains two amino-termay be a key event during signaling by SEV.
Results
A 115 kDa Protein Is a Target of the PTP Activity of CSW Our approach to understanding the role of CSW during SEV signaling was to identify physiological substrates of the phosphatase activity of CSW. The biochemical approach that we used was modeled after experiments which showed that a catalytically inactive mutant form of the MKP-1 phosphatase forms stable complexes in vivo with its substrates, phosphorylated p42 mapk and p44 mapk (Sun et al., 1993) . We constructed an equivalently mutated form of csw, csw
C583S
, and expressed the resulting protein (CSW CS ) in Drosophila SL2 cells under the control of the Actin5C promoter (Simon et al., 1989) . The resulting cell line (SL2-CSW CS ) was examined for tyrosine-phosphorylated proteins that could be coprecipitated with CSW CS using anti-CSW antisera. A 115 kDa phosphotyrosine-containing protein (p115) was specifically detected in CSW immunoprecipitates from lysates of SL2-CSW CS cells but was barely detectable in anti-CSW immunoprecipitates of either untransfected SL2 cells or SL2 cells that overexpressed wild-type csw (SL2-CSW; Figure 1A ). Antiphosphotyrosine immunoblotting of whole cell extracts from SL2-CSW CS cells further indicated that p115 was one of the major tyrosine-phosphorylated proteins present in SL2-CSW CS cells but was not a major phosphotyrosine-containing protein in SL2 or SL2-CSW cells ( Figure 1B) .
The most likely explanation for these results is that p115 is phosphorylated normally by endogenous kinases present in SL2 cells, but that SL2 cells contain active CSW, and perhaps other PTPs, which rapidly de- order to demonstrate that phosphorylated p115 and (B) shows an antiphosphotyrosine immunoblot of total cell extracts from these same cell lines. The position of the tyrosine-phosphorywild-type CSW can associate in vivo, we examined lated p115 protein that coprecipitates with CSW CS is indicated.
whether phosphorylated p115 could be coprecipitated (C) shows an antiphosphotyrosine immunoblot of anti-CSW immuwith wild-type CSW from normal SL2 cells which had noprecipitates from SL2 cells that were treated with the PTP inhibitor been treated with the membrane-permeable PTP inhibipervanadate for 5 min prior to lysis. Similar results were obtained tor pervanadate (Fantus et al., 1989; Heffetz et al., 1990) . (data not shown). Tyrosine-phosphorylated p115 was readily detectable in anti-CSW immunoprecipitates from CSW and possibly other PTPs are prevented from cataeither SL2 or SL2-CSW CS cells after treatment with perlyzing the dephosphorylation of p115. vanadate ( Figure 1C ). With increasing concentrations of In order to demonstrate that CSW could use phosthe PTP inhibitor, the signal obtained in antiphosphophorylated p115 as a substrate, tyrosine-phosphorytyrosine immunoblots was enhanced several-fold, and lated p115 was isolated from pervanadate-treated SL2 the p115 band showed decreased electrophoretic mocells by coprecipitation with anti-CSW antiserum. A puribility, suggesting that p115 might be phosphorylated fied bacterially expressed fusion protein (GST-CAT) that on multiple tyrosine residues under these conditions. consisted of the CSW catalytic domain fused to glutathiTreatment with pervanadate also resulted in phosphoryone S-transferase (GST) was then added to the immunolation of CSW on tyrosine residues. In addition to p115, precipitate, and the dephosphorylation of p115 was two other tyrosine-phosphorylated proteins with molecmonitored by antiphosphotyrosine immunoblotting after ular masses of 170 kDa (p170) and 190 kDa (p190), re-SDS-polyacrylamide gel electrophoresis (SDS-PAGE). spectively, could be coprecipitated both with CSW and
The addition of GST-CAT resulted in the rapid dephos-CSW CS . These results show that wild-type CSW can interact stably with phosphorylated p115, provided that phorylation of p115 (Figure 2 ). In contrast, the addition shows an antiphosphotyrosine immunoblot of whole cell exwere then incubated with either no added protein, GST, GST fused tracts. The cell line used to prepare the extract is indicated above to the catalytic domain of CSW, or GST fused to an inactive CSW each lane. catalytic domain containing the csw C583S mutation. Dephosphoryla-(B) Binding of p115 to the CSW SH2 domains. In order to remove tion of p115 was monitored by antiphosphotyrosine immunoblot.
excess CSW CS that was not bound to p115, the CSW CS /p115 complex The positions of CSW and the p190, p170, and p115 proteins that was partially purified from SL2-CSW CS cells by ion-exchange chroprecipitate with CSW from pervanadate-treated cells are indicated.
matography. The column eluate was subjected to precipitation with either anti-CSW antiserum, antiphosphotyrosine antibodies, GST bound to glutathione-agarose beads, or GST-SH2SH2 bound to of GST alone or a GST-CAT protein containing the inactiglutathione-agarose beads. The presence of p115 was detected by vating csw C583S substitution (GST-CAT CS ) had no effect antiphosphotyrosine immunoblot. Despite the presence of numeron the phosphotyrosine content of p115. These results ous phosphotyrosine-containing proteins in the sample, only p115 could be precipitated by the SH2 domains of CSW.
indicate that CSW can dephosphorylate p115 in vitro and support the proposal that phosphorylated p115 is a direct target for CSW dephosphorylation. Tyrosinephosphorylated p170 and p190 were also rapidly dephosphorylated p115 was confirmed by demonstrating phosphorylated by the addition of GST-CAT, indicating that an immobilized fusion protein containing GST and that these proteins might also be possible substrates the SH2 domains of CSW (GST-SH2SH2) was able to of CSW. precipitate phosphorylated p115 from extracts of SL2-CSW CS cells. In order to generate conditions in which The Interaction Between p115 and CSW CS GST-SH2SH2 could effectively compete with CSW CS for Depends on the SH2 Domains of CSW binding to phosphorylated p115, the bulk of free CSW
CS
The presence of phosphorylated tyrosine residues on was removed from the extracts of SL2-CSW CS cells by p115 suggested that the association of CSW and p115 anion exchange chromatography. After removal of free might involve interactions between phosphorylated CSW CS , GST-SH2SH2 was able effectively to precipitate p115 and one or both of the SH2 domains of CSW. In phosphorylated p115 ( Figure 3B ). Despite the presence order to address this issue, we established an SL2 cell of many tyrosine-phosphorylated proteins in the eluate, line, which stably expressed CSW CS , that contained p115 was the only tyrosine-phosphorylated protein that inactivating mutations in both of the SH2 domains bound to GST-SH2SH2, indicating the high degree of (CSW SH2*SH2*CS ). Residues arginine-32 and arginine-137 specificity in the interaction of tyrosine-phosphorylated were exchanged for lysine residues. These residues are p115 and the SH2 domains of CSW. These results conpart of the highly conserved FLVRES motif and corfirm that the SH2 domains of CSW play an important respond to arginine-175 of c-src, a residue which is crirole in p115 recognition. tical for interaction of the SH2 domain with tyrosinephosphorylated ligands (Pawson, 1995) . Lysates of this cell line were analyzed for the presence of tyrosinep115 Is Tyrosine-Phosphorylated in Response to Constitutively Active SEV phosphorylated p115 ( Figure 3A ). The expression of CSW SH2*SH2*CS was not sufficient to induce an accumulaSince SL2 cells do not express SEV, the tyrosine phosphorylation of p115 in SL2-CSW CS cells must be catation of tyrosine-phosphorylated p115. These results suggest that one or both of the SH2 domains of CSW lyzed by other kinases that are present in these cells. However, the crucial role of CSW during SEV signaling are important for the interaction of CSW with phosphorylated p115.
suggested that p115 might also be a substrate for SEV. In order to examine the effect of SEV activity on p115 The ability of the SH2 domains of CSW to interact with phosphorylation of p115. Furthermore, the apparent shift in mobility upon SEV S11 induction suggested that at least some of the induced p115 phosphorylation occurred at sites that were distinct from those sites which were phosphorylated in SL2-CSW CS cells that did not express SEV. As a control for the effects of heat shock on p115 phosphorylation, we also examined the tyrosine phosphorylation and mobility of p115 from heatshocked SL2-CSW CS cells. In this case, no increase in tyrosine-phosphate content was observed, though there was a short-lived decrease in electrophoretic mobility that might be due to other covalent modifications of p115, such as serine/threonine phosphorylation.
These results suggest that p115 is either a direct or indirect target for the kinase activity of SEV. One issue that is raised by these results is whether p115 might also be a target for phosphorylation in response to the induction of other RTKs. Therefore, we examined the effect on p115 phosphorylation of activation of the Drosophila insulin receptor in response to mammalian insulin (Fernandez et al., 1995) . SL2 and SL2-CSW CS cells were each starved for 24 hr in serum-free media and then stimulated with increasing concentrations of insulin. Antiphosphotyrosine immunoblot analysis revealed a dose-dependent increase in tyrosine phosphorylation of a 170 kDa protein that most likely represented the insulin receptor according to its response to insulin and promoter. Cells either were not heat shocked or were placed at 37ЊC for 30 min and then allowed to recover for 2, 4, or 6 hr. The lower panel of (A) shows an anti-SEV immunoblot of the same extracts that shows the accumulation of the 58 kDa subunit of SEV. Induction of
Purification of p115
SEV activity leads to an increase in the intensity of antiphosphotyro-
The evidence that p115 is both a substrate for dephossine staining of p115 and a shift of p115 to a larger apparent molecuphorylation by CSW and a target for either direct or lar mass. In contrast, heat-shock treatment of SL2-CSW CS cells leads only to a much more transient change in electrophoretic mobilindirect phosphorylation by SEV indicated that p115 ity and no apparent change in the phosphotyrosine content of p115. might play a crucial role in signaling by SEV. We sought (B) shows an antiphosphotyrosine immunoblot of extracts prepared to investigate this role both by identifying the gene that from SL2-CSW CS cells that were serum-starved for 24 hr and then encoded p115 and by studying mutations that inactitreated with various concentrations of bovine insulin. The concenvated p115. In order to identify the p115 gene, we puritration of insulin (ng/ml) used is given above each lane. Addition of fied sufficient p115 for microsequence analysis. The puinsulin results in significant activation and phosphorylation of insulin receptor without any observable change in the phosphorylation or rification scheme was based on the ability of CSW CS to electrophoretic mobility of p115.
bind phosphorylated p115 specifically and to prevent dephosphorylation by cellular phosphatases including CSW. Cytosolic extracts of SL2-CSW CS cells were prephosphorylation, we expressed a constitutively actipared in the absence of PTP inhibitors and allowed to vated version of SEV (SEV S11 ) under heat-shock promoter undergo dephosphorylation by endogenous PTPs for 50 control in SL2 cells (SL2-SEV S11 cells) or in SL2 cells that min at room temperature. During this period, virtually also expressed CSW CS (SL2-CSW CS SEV S11 cells; Basler all phosphotyrosine-containing proteins in the extract et al., 1991; Simon et al., 1993) . Upon heat-shock inducwere dephosphorylated, with the exception of p115. Foltion, SEV S11 is synthesized as a 90 kDa precursor, which lowing this treatment, the extract was denatured by boilis then cleaved to yield 58 and 48 kDa forms (Simon et ing in an SDS-containing buffer, diluted to lower the al., 1991). While SEV S11 autophosphorylation could be concentration of SDS, and then immunoprecipitated readily detected in SL2-SEV S11 cells, SEV S11 expression with antiphosphotyrosine antibodies. This procedure redid not result in other obvious changes in the spectrum sulted in a preparation that contained a single major of cellular tyrosine phosphorylation (data not shown). In protein band that was 115 kDa in apparent molecular contrast, induction of SEV S11 in cells expressing CSW CS mass. We used this protocol to purify approximately 4 led to an increase in the tyrosine-phosphate content and g of p115 from 4 ϫ 10 9 SL2-CSW CS cells. The sequence a concurrent decrease in the electrophoretic mobility of of a single tryptic peptide (XXMSVGNLYSQGXN) was p115 ( Figure 4A) . Thus, the induction of SEV activity can lead either directly or indirectly to enhanced tyrosine obtained.
A Screen for Mutations Affecting CSW Function
as dominant suppressors of the ability of a membraneAt the same time that we sought to identify the gene targeted form of CSW (CSW src90 ) to induce R7 developthat encoded p115, we also sought to isolate mutant ment in the cone cell precursors (Figures 5D and 5H ; alleles of the gene encoding p115 and of other genes Allard et al., 1996 (Allard et al., 1996) . The inhibitory effect of CSW CS proteins expressed under the control of sevenless tranexpression could be entirely reversed by the expression scriptional enhancers (Basler et al., 1991 ; Fortini et al., of wild-type CSW (data not shown).
1992; Dickson et al., 1992) . The external eye morphology We reasoned that if p115 was an important target of is a sensitive assay for limiting components of the signal-CSW during photoreceptor development, then lowering ing pathway that are downstream of these activated the amount of functional p115 present during photoreproteins, because expression of the activated proteins ceptor development by inactivating one copy of the results in a dose-dependent eye roughness owing to p115 gene might affect the severity of the phenotype the abnormal recruitment of cone cell precursors to the induced by P[sevhs-csw CS ]. However, since we did not R7 developmental fate (Dickson et al., 1995;  Chang et al., know whether p115 might need to be dephosphorylated Therrien et al., 1995) . Heterozygosity for E(csw CS ) to allow its active participation in signaling, or whether 3A suppressed the phenotype caused by SEV S11 but dephosphorylation might instead prevent phosphoryhad no effect on the phenotype caused by RAS1 V12 or lated p115 from blocking signaling, we could not predict RAF TOR ( Figure 5 ). These results indicated that the level whether p115 mutations would make the P[sevhs-csw CS ]
of E(csw CS )3A function was limiting during signaling by phenotype more or less severe. We therefore mutagenactivated SEV, but not during signaling by either actiized flies and screened for mutations that acted either as vated RAS1 or RAF. These data are consistent with dominant enhancers or suppressors of P[sevhs-csw CS ]. placement of the E(csw CS )3A protein on a part of the The complete results of the mutagenesis screen will SEV signaling pathway that is either before RAS1/RAF be published elsewhere. In summary, approximately activation or in a pathway that is parallel to the activation 75,000 progeny of ethylmethylsulfonate-treated flies of RAS1 and RAF. were screened. Mutations were identified which affected several genes that were already known to encode important components of the SEV signaling pathway. (Simon et al., 1991; O'Neill et al., 1994;  of E. Hafen, for mutations that dominantly suppress the Brunner et al., 1994a Figures 5C and 5D ) was stronger than the homology to known proteins except for the presence of effects of mutations in any of the other novel complea pleckstrin homology domain (see Raabe et al., 1996 , mentation groups that we identified. Since our data sugfor a full discussion of the dos sequence; Gibson et al., gested that p115 was the direct target for CSW action, 1994). However, immunoblotting with antibodies to DOS we expected that mutations in the p115 gene would indicates that DOS migrates as a 115 kDa protein in have a profound effect on the P[sevhs-csw CS ] phenotype. Third, E(csw CS )3A mutations are capable of acting SDS-PAGE (T. R. and E. Hafen, unpublished data). We (A) shows a scanning electron micrograph (SEM) of a phenotypically wild-type eye of a w 1118 fly. The eye is smooth in appearance and has the normal regular array of photoreceptors. This can be seen in apical tangential sections of w 1118 flies (E). The pattern of seven photoreceptors can be seen by observing the darkly staining structures that are the rhabdomeres (light-sensing organelles) of each photoreceptor. The presence of R7 cells can be scored by the presence of the R7 rhabdomere, which is smaller and more centrally located than the rhabdomeres of R1-R6. (B) shows an SEM of an eye of a heterozygous P[sevhs-csw CS ] fly. The surface of the eye is roughened owing to abnormalities in the structure of the underlying ommatidia (F), including the frequent absence of R7 and one or two of the R1-R6 class photoreceptors. Examination of the neuronal development of these eyes indicates that R3 and R4 are most frequently absent (data not shown). (C) shows an SEM of a fly that is heterozygous both for P[sevhs-csw CS ] and for E(csw CS )3A 1.46 . therefore directly tested whether dos encoded p115 by noblot analysis, both of anti-CSW immunoprecipitates from SL2-CSW CS cells and of purified p115 preparations searching for the p115 peptide sequence (XXMSV GNLYSQGXN) in DOS. A match was found in the pre-( Figure 6 ). These results clearly show that the tyrosinephosphorylated p115 protein that coprecipitated with dicted DOS tryptic fragment SSMSVGNLYSQGGN-GASGMR (amino acids 816-835). This indicated that dos CSW CS and the protein that we purified for microsequence analysis are recognized by anti-DOS antiencoded the p115 substrate of CSW. In order to validate this conclusion further, we performed anti-DOS immubodies.
the formation of a complex between CSW CS and phosphotyrosine-containing protein, DOS. Several lines of biochemical evidence suggest that DOS is a genuine substrate for CSW. First, previous studies of other PTPs in which the equivalent cysteine residue has been mutated to serine suggest that this mutation creates a catalytic domain that is inactive but that retains the ability to bind substrate with high affinity (Sun et al., 1993; Milarski et al., 1993; Guan and Dixon, 1991) . Second, the addition of a fusion protein containing a catalytically active domain of CSW to extracts containing tyrosinephosphorylated DOS leads to the rapid dephosphorylation of DOS. Finally, the ability of the CSW CS protein dues is maintained by the action of a presently unidentified kinase. The activation of SEV by BOSS then leads to activation of the PTP activity of CSW and the subseDiscussion quent dephosphorylation of DOS by CSW. Dephosphorylated DOS would then be free to participate actively in During Drosophila ommatidial development, effective signaling by the SEV RTK is essential for the precursors the initiation of R7 photoreceptor development. Proof of this model for CSW and DOS function will require of R7 photoreceptor cells to differentiate as neurons. Previous studies have provided evidence for the possiidentification of the particular phosphotyrosine residues of DOS which are targets for dephosphorylation by ble existence of two signaling pathways that are crucial for signaling by SEV. The better characterized pathway CSW. This model predicts that mutations which reduce the phosphorylation of these specific tyrosines might is initiated by recruitment of the SOS-DRK signaling complex to the activated and autophosphorylated SEV generate overly active DOS. Since the only recognizable feature of the predicted (Zipursky and Rubin, 1994) . This recruitment step leads to the activation of RAS1 and the stimulation of a MAPK DOS peptide sequence is the presence of a pleckstrin homology domain, we presently can only speculate on pathway that is very similar to those that have been characterized in vertebrate cells. The less characterized the precise role of DOS function after dephosphorylation by CSW during SEV signaling (Raabe et al., 1996) . The pathway involves the action of the SH2 domaincontaining PTP CSW. Our previous genetic studies of ability of DOS mutations to act as dominant suppressors of the phenotype caused by expression of an activated dominant csw alleles have indicated that CSW function is essential for SEV action and have further suggested SEV but not the same phenotype when induced by activated RAS1 or RAF expression suggests two possible that at least a portion of CSW function is either downstream of RAS1 activation or else in a pathway that acts placements of DOS action in the SEV signaling pathway. The simplest model is that the sole important function in parallel to the RAS1/RAF pathway (Allard et al., 1996) . In this study, we have further characterized the action of DOS is to contribute to RAS1 activation ( Figure 7A ). DOS mutations would thus fail to act as heterozygous of CSW during SEV signaling by identifying a substrate for the PTP activity of CSW.
suppressors of RAS1 V12 signaling because the RAS1 V12 protein would already be fully activated. The second In our biochemical search for CSW substrates, we employed a catalytically inactive CSW, CSW CS , to trap possibility is that DOS functions in a pathway that normally acts in conjunction with RAS1 during SEV signaling a substrate in a complex with CSW. We found that overexpression of CSW CS in Drosophila SL2 cells resulted in ( Figure 7B ). This model postulates that SEV normally that this model does not exclude the possibility that DOS and CSW also contribute to RAS1 activation. Each of these models is entirely consistent with presently available genetic data. Support for the first model comes from several studies of CSW and its mammalian homolog, SH-PTP2, which have suggested that the level of CSW function can affect RAS1 and MAPK activation (Lu et al., 1993; Li et al., 1994; Bennett et al., 1994; Milarski and Saltiel, 1994; Noguchi et al., 1994; Tang et al., 1995; Zhao et al., 1995) . Support for the second model comes both from numerous biochemical studies of vertebrate RTK signaling which have demonstrated that RTKs stimulate multiple signaling pathways and from our previous genetic experiments, which have shown that CSW function during R7 development cannot be placed genetically solely upstream of RAS1 activation (Allard et al., 1996) . A fuller understanding of the role of DOS and CSW will require elucidation of the activity of DOS and the targets of DOS action. These models are each consistent with all of our present data, but both leave many issues unresolved. One important question is the identity and possible regulation of the kinase that maintains DOS in a phosphorylated state prior to the activation of SEV. Since this phosphorylation is proposed to maintain DOS in an inactive state, we predict that mutations which decrease the activity of this kinase might be expected to act as suppressors of the phenotype caused by CSW CS expression. Several new suppressor loci were found in our genetic screen for CSW CS modifiers, but the products of these genes have not yet been characterized.
Another critical issue raised by our proposed models is how CSW activity might be regulated by SEV. It is important to note that none of our present genetic data demands that the level of CSW activity change during SEV signaling. Another possibility is that CSW maintains DOS in its dephosphorylated state at all times. Our data suggest that this may be the case in SL2 cells, because phosphorylation of DOS is only detectable in the presence of CSW CS . Nevertheless, regulation of CSW by SEV is an attractive proposal, because RTK induced activation of the mammalian homolog of CSW, SH-PTP2, has been previously reported (Vogel et al., 1993; Lechleider et al., 1993) . SH-PTP2 activation appears to be mediated by binding of the SH2 domains of SH-PTP2 to specific Feng et al., 1993; Lechleider et al., 1993) .
Only the phosphorylated tyrosine residue or residues of DOS which
In some cases, phosphorylation of SH-PTP2 by the actiare a substrate for dephosphorylation by CSW are indicated. Other vated RTK also occurs and may contribute to the entyrosine residues which may be sites for phosphorylation by SEV hancement of SH-PTP2 activity (Vogel et al., 1993; Feng are not shown. See Discussion for details. Lechleider et al., 1993) . This model for PTP activation is unlikely to apply to the interaction of CSW directs R7 development by combining a moderate level with SEV. While we have detected coimmunoprecipitaof RAS1 activation with the stimulation of other positive tion of CSW and SEV, this interaction is dependent neisignaling molecules such as DOS and CSW, but that ther on SEV phosphorylation nor on functional SH2 dooverexpression of mutationally activated RAS1 or RAF mains of CSW (unpublished data). Furthermore, SEV activates the MAPK cascade so strongly that activation appears to be unable to induce CSW phosphorylation of the other branches of the SEV signaling pathway is in SL2 cells. Instead, our results suggest that the primary no longer required. Under these conditions, the reducfunction of the SH2 domains of CSW during SEV signaltion of function of the CSW-DOS signaling branch ing may be the recognition of DOS. caused by the inactivation of only one allele of DOS The role of DOS phosphorylation by SEV is another might have little effect on signaling. Thus, DOS mutaimportant issue that will require further study. Our curtions would fail to act as dominant suppressors of the rent results indicate that SEV activation can lead to enhanced DOS phosphorylation in cultured Drosophila activated RAS1 and RAF phenotypes. It is worth noting Protein Analysis cells, but we do not have any direct evidence for SEV Immunoblotting and immunoprecipitation were prepared as previphosphorylation of DOS in the R7 precursor cell during ously described (Herbst et al., 1995) . The following antibodies were SEV signaling. Several roles for this putative phosphoryused: PY20, a monoclonal antibody against phosphotyrosine (Translation of DOS by SEV seem possible. DOS phosphoryladuction Laboratories); monoclonal antibody 78C10, which recogtion by SEV could act to enhance the ability of the SH2 nizes the catalytic domain of SEV; CT-1, a rat polyclonal antiserum raised against a GST-fusion protein containing the carboxy-terminal domains of CSW to bind to DOS and thus be a mecha-159 amino acids of CSW; CT-1-2, a polyclonal rabbit antiserum nism by which SEV stimulates CSW to dephosphorylate raised against a GST-fusion protein containing the carboxy-terminal key phosphotyrosines of DOS. Alternatively, phosphory-610 amino acids, and affinity purified with the antigen used to raise lation of DOS by SEV could stimulate a presently un-CT-1. The serum CT-1 was used for all immunoprecipitations of known catalytic activity of DOS. Finally, phosphorylation CSW, while CT-1-2 was used for immunoblotting. Anti-DOS antibodof DOS might allow DOS to bind to other signaling moleies are described by Raabe et al. (1996) . The GST expression vectors used were either pGEX (Guan and Dixon, 1991) or pGEX-2TK (Pharcules in a manner similar to IRS-1 and GAB-1 (Myers macia).
and Morris, 1993; Hogado-Madruga et al., 1996) . InterFor in vitro dephosphorylation experiments, the catalytic domain estingly, each of these proteins shares with DOS the of CSW (residues 231-681) was expressed as a GST-fusion protein property of having an amino-terminal pleckstrin homol-(GST-CAT). SL2 cells were incubated with 200 M pervanadate for ogy domain (Gibson et al., 1994) . PTP2 from insulin-treated cells (Yamauchi et al., 1995) . other study detected a 120 kDa tyrosine-phosphorylated
The column was washed with buffer A/100 mM NaCl and bound protein whose properties are similar to the Drosophila proteins eluted with buffer A/200 mM NaCl. For precipitations with p115 (Milarski and Saltiel, 1994) . The 120 kDa protein GST-SH2SH2 (amino acids 1-218 of CSW), the eluate was adjusted was only tyrosine-phosphorylated in cells expressing an to 150 mM NaCl and 0.5% Triton X-100 and mixed with glutathione inactive SH-PTP2 and could be precipitated by the SH2 beads to which GST-SH2SH2 was bound. 90ЊC for 5 min. The lysate was then diluted with 9 vol of immunoprecipitation washing buffer containing 0.3% Triton X-100 and loaded on an anti-phosphotyrosine (PY20) column. The column was washed Experimental Procedures with immunoprecipitation washing buffer, and tyrosine-phosphorylated proteins were eluted in washing buffer containing 50 mM Drosophila Culture and Histology p-nitrophenylphosphate (Sigma). The eluate was concentrated in Fly culture, crosses, mutagenesis, and germline transformation were a Centricon concentrator (Amicon), subjected to SDS-PAGE, and performed using standard procedures. Mutagenized males from an transferred onto nitrocellulose. A single protein of 115 kDa could isogenic stock were crossed to females of the genotype TM3, be stained on the membrane with amidoblack. The band was ex-P[sevhs-csw cs ]/TM6b. F1 progeny were scored for modifications cised from the membrane and used for microsequencing. in the rough-eye phenotype caused by the expression of CSW cs . Histological analysis of flies was as previously described (Simon et al., 1991) . The Drosophila Schneider cell line 2 (SL2) was maintained
